Last10K.com

Acro Biomedical Co., Ltd. (ACBM) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2020

SEC Filings

ACBM Quarterly Reports

Acro Biomedical Co., Ltd.

CIK: 1622996 Ticker: ACBM
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2020
May 14, 2020
Document And Entity Information [Abstract]  
Entity Registrant NameACRO BIOMEDICAL CO., LTD. 
Entity Central Index Key0001622996 
Entity Current Reporting StatusNo 
Current Fiscal Year End Date--12-31 
Entity Filer CategoryNon-accelerated Filer 
Entity Common Stock, Shares Outstanding 47,760,000
Document Type10-Q 
Document Period End DateMar. 31, 2020 
Amendment Flagfalse 
Document Fiscal Year Focus2020 
Document Fiscal Period FocusQ1 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Interactive Data CurrentYes 

View differences made from one quarter to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..

Continue

Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue